Skip to main content

and
Your search also matched 21 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

A Monoclonal Antibody Against β1 Integrin Inhibits Proliferation and Increases Survival in an Orthotopic Model of High-Grade Meningioma

Include preview-only content
  1. Article

    Open Access

    Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

    Cancer-associated fibroblasts (CAFs) are activated fibroblasts constituting the major stromal components in many types of cancer. CAFs contribute to hallmarks of cancer such as proliferation, invasion and immu...

    Ming Li, Guo** Li, Juri Kiyokawa, Zain Tirmizi in Acta Neuropathologica Communications (2020)

  2. Article

    Open Access

    Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma

    PARP inhibitors (PARPis) have clinical efficacy in BRCA-deficient cancers, but not BRCA-intact tumors, including glioblastoma (GBM). We show that MYC or MYCN amplification in patient-derived glioblastoma stem-lik...

    Jian-Fang Ning, Monica Stanciu, Melissa R. Humphrey, Joshua Gorham in Nature Communications (2019)

  3. Article

    Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors

    In the version of this article originally published, the figure callout in this sentence was incorrect: “Furthermore, in S1P1-KI mice themselves, whereas PD-1 blockade was ineffectual as monotherapy, the effec...

    Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama in Nature Medicine (2019)

  4. Article

    Open Access

    Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy

    Intratumoural heterogeneity underlies tumour escape from molecularly targeted therapy in glioblastoma. A cell-based model preserving the evolving molecular profiles of a tumour during treatment is key to under...

    Shota Tanaka, Samantha Luk, Juri Kiyokawa, Maristela L. Onozato in Scientific Reports (2019)

  5. Article

    Open Access

    Identification of diagnostic serum protein profiles of glioblastoma patients

    Diagnosis of a glioblastoma (GBM) is triggered by the onset of symptoms and is based on cerebral imaging and histological examination. Serum-based biomarkers may support detection of GBM. Here, we explored ser...

    Anja Elstner, Florian Stockhammer, Trong-Nghia Nguyen-Dobinsky in Journal of Neuro-Oncology (2011)

  6. Article

    Open Access

    Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases

    Oncolytic herpes simplex virus (HSV) vectors that specifically replicate in and kill tumor cells sparing normal cells are a promising cancer therapy. Traditionally, recombinant HSV vectors have been generated ...

    Toshihiko Kuroda, Robert L Martuza, Tomoki Todo, Samuel D Rabkin in BMC Biotechnology (2006)

  7. Article

    Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

    In the search for novel cancer therapies that can be used in conjunction with existing treatments, one promising area of research is the use of viral vectors and whole viruses. This review describes the underl...

    David Kirn, Robert L. Martuza, James Zwiebel in Nature Medicine (2001)

  8. Article

    Act locally, think globally

    Locally growing malignant brain tumors provide a reasonable starting point for develo** targeted strategies of anti-cancer therapy (pages 1354–1368).

    Robert L. Martuza in Nature Medicine (1997)